These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration. Jappe U, Reinhold D, Bonnekoh B. Contact Dermatitis; 2002 Jan; 46(1):29-32. PubMed ID: 11918584 [Abstract] [Full Text] [Related]
4. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Jappe U, Juschka U, Kuner N, Hausen BM, Krohn K. Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846 [Abstract] [Full Text] [Related]
5. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Boehncke WH, Weber L, Gall H. Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822 [Abstract] [Full Text] [Related]
6. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH. Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404 [Abstract] [Full Text] [Related]
7. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543 [Abstract] [Full Text] [Related]
8. [A study of 19 cases of allergy to heparins with positive skin testing]. Phan C, Vial-Dupuy A, Autegarden JE, Amsler E, Gaouar H, Abuaf N, Pecquet C, Francès C, Soria A. Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090 [Abstract] [Full Text] [Related]
9. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin. Martin L, Machet L, Gironet N, Pouplard C, Gruel Y, Vaillant L. Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857 [No Abstract] [Full Text] [Related]
10. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection. Trautmann A, Seitz CS. Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992 [Abstract] [Full Text] [Related]
11. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids]. Figarella I, Barbaud A, Lecompte T, De Maistre E, Reichert-Penetrat S, Schmutz JL. Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896 [Abstract] [Full Text] [Related]
12. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Ludwig RJ, Beier C, Lindhoff-Last E, Kaufmann R, Boehncke WH. Contact Dermatitis; 2003 Sep; 49(3):158-9. PubMed ID: 14678213 [No Abstract] [Full Text] [Related]
13. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Grims RH, Weger W, Reiter H, Arbab E, Kränke B, Aberer W. Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880 [Abstract] [Full Text] [Related]
14. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study. Grassegger A, Fritsch P, Reider N. Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243 [Abstract] [Full Text] [Related]
15. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update. Jappe U. Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645 [Abstract] [Full Text] [Related]
16. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration. Liew G, Campbell C, Thursby P. ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103 [No Abstract] [Full Text] [Related]